Baxion
Screening
Tags
Alerts
Theme
Filana Therapeutics, Inc.
FLNA
·
NASDAQ
·
$1.41
Share Price as of 11/2
·
$68M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
07/29/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
10/20/26
8-K
Regulation FD Disclosure; Other Events
09/22/26
8-K
Delisting or Transfer
09/18/26
8-K
Results of Operations
07/29/26
8-K
Change in Directors or Officers; Shareholder Vote Results
06/15/26
Prospectuses and Registrations
Filter
424B2
Prospectus for primary offering
12/05/25
S-3
Shelf registration
11/13/25
424B2
Prospectus for primary offering
01/03/24
424B5
Prospectus supplement
05/01/23
S-3ASR
Automatic shelf registration
05/01/23
Proxies
Filter
DEF 14A
Definitive proxy
04/28/26
DEF 14A
Definitive proxy
04/14/25
PRE 14A
Preliminary proxy
04/03/25
DEF 14A
Definitive proxy
03/26/24
DEF 14A
Definitive proxy
03/27/23
Ownership
Filter
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
09/30/26
Form 4
Insider transaction
11/25/25
Form 4
Insider transaction
11/24/25
Form 4
Insider transaction
11/20/25
Other
Filter
ARS
Annual report to shareholders
04/28/26
EFFECT
Request for effectiveness
12/05/25
CORRESP
Correspondence with the SEC
12/03/25
ARS
Annual report to shareholders
04/14/25
25-NSE
Removal from listing
05/03/24
Latest Filings
Filter
8-K
Current report
10/20/26
8-K
Regulation FD Disclosure; Other Events
09/22/26
8-K
Delisting or Transfer
09/18/26
10-Q
Q2 ended 06/30/26
07/29/26
8-K
Results of Operations
07/29/26
Ownership
Filter
Form 4
Insider transaction
10/01/26
Form 4
Insider transaction
09/30/26
Form 4
Insider transaction
11/25/25
Form 4
Insider transaction
11/24/25
Form 4
Insider transaction
11/20/25